Cardiovascular Pharmacology: Open Access

Current State of Regenerative Medicine: Moving Stem Cell Research from Animals into Humans for Clinical Trials

The openness of pluripotent epigenome - Defining the genomic integrity of stemness for regenerative medicine

Mohammadi, Elmira, et al. "Reteplase: structure, function, and production." Advanced biomedical research 8 (2019).

Direct conversion of pluripotent human embryonic stem cells under defined culture conditions into human neuronal or cardiomyocyte cell therapy derivatives

Guo, Xin, et al. "DPP-4 inhibition as a therapeutic strategy to ameliorate diabetic metabolic memory." International journal of cardiology 247 (2017): 40.

Viñas Esmel, Esther, José Naval Álvarez, and Emilio Sacanella Meseguer. "The legacy effect in the prevention of cardiovascular disease." Nutrients 12.11 (2020): 3227.

DONEPEZIL HYDROCHLORIDE MITIGATES CONSEQUENCES OF ACUTE MYOCARDIAL INFARCTION IN MALE ALBINO RATS

Viñas Esmel, Esther, José Naval Álvarez, and Emilio Sacanella Meseguer. "The legacy effect in the prevention of cardiovascular disease." Nutrients 12.11 (2020): 3227.

Upadhya, Kavya R., et al. "Sustained ventricular arrhythmias in an asymptomatic child posted for laparoscopic rectopexy: An anesthetist's dilemma?." Annals of cardiac anaesthesia 21.3 (2018): 343.

The effects of acetylcholinesterase inhibitors on the heart in acute myocardial infarction and heart failure: From cells to patient reports

Arun Kumar, R., R. Kavya Manaswini, and S. Anitha Sri. "Innovative approaches in the field of cardiology." Res Rev Biosci 11.3 (2016): 109.

Kanic, Vojko, et al. "GPIIb-IIIa receptor inhibitors in acute coronary syndrome patients presenting with cardiogenic shock and/or after cardiopulmonary resuscitation." Heart, Lung and Circulation 27.1 (2018): 73-78.

Donepezil, an acetylcholinesterase inhibitor, attenuates LPS-induced inflammatory response in murine macrophage cell line RAW 264.7 through inhibition of nuclear

Backhaus, Tina, et al. "Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry." Clinical Research in Cardiology 107.5 (2018): 371-379.

Liu, Ping-Yen, et al. "Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy." Cardiovascular Intervention and Therapeutics (2021): 1-10.

Potassium and Chloride Ion Channels in Cancer: A Novel Paradigm for Cancer Therapeutics

Tokimasa, Satoshi, et al. "Multicenter research of bleeding risk between prasugrel and clopidogrel in Japanese patients with coronary artery disease undergoing percutaneous coronary intervention." Heart and vessels 34.10 (2019): 1581-1588.

Nishikawa, Masakatsu, et al. "Risk of bleeding and repeated bleeding events in prasugrel-treated patients: a review of data from the Japanese PRASFIT studies." Cardiovascular intervention and therapeutics 32.2 (2017): 93-105.